The primary mechanism of action for B Cell Engagers involves creating a cytolytic synapse between the T cell and the cancer cell. Once attached, the T cell is activated and releases cytotoxic molecules like perforin and granzymes, which induce apoptosis in the cancer cell. This process effectively transforms the patient's T cells into targeted cancer killers, without the need for direct genetic modification of the T cells.
